# Intra-Umbilical Vein Oxytocin Injection as an Adjunct to Active Management of the Third Stage of Labour

> **NCT07436286** · NA · COMPLETED · sponsor: **Dangana Zakari Adeka** · enrollment: 416 (actual)

## Conditions studied

- Postpartum Hemorrhage (PPH)
- Postpartum Hemorrhage Third Stage of Labour Retained Placenta

## Interventions

- **DRUG:** Oxytocin
- **OTHER:** Normal Saline (Placebo)

## Key facts

- **NCT ID:** NCT07436286
- **Lead sponsor:** Dangana Zakari Adeka
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-01
- **Primary completion:** 2019-08-31
- **Final completion:** 2019-08-31
- **Target enrollment:** 416 (ACTUAL)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07436286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07436286, "Intra-Umbilical Vein Oxytocin Injection as an Adjunct to Active Management of the Third Stage of Labour". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07436286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*